Bli medlem
Bli medlem

Du är här


CELLAVISION: Redeye initiates coverage of Cellavision

We initiate coverage of CellaVision, the undisputed market leader in
digital microscopy for hematology. While the share gives investors
exposure to an important long-term technology shift and the company
has performed impressively, we see limited short-term upside
potential in the share at current levels. However, we see long-term
potential in the case and believe that short-term dips can provide
good opportunities to buy the share.

Read more and download the research update:

Start following companies at Redeye to receive the latest equity
research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment


Författare Cision News

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.